September 14, 2026

Supporting FDA’s Office of Computational Science across clinical and nonclinical programs

Cognizance Technologies has been awarded a task order under the FDA RRS BPA to provide OCS Clinical and Nonclinical Services Support, extending the company’s work with the U.S. Food and Drug Administration.

The engagement brings Cognizance Technologies’ technical and scientific expertise to programs supporting the FDA’s clinical and nonclinical priorities, with an emphasis on the accuracy, quality, and consistency required across federal health and regulatory environments.

With experience supporting complex federal health programs, Cognizance Technologies brings a strong understanding of the technical and scientific requirements involved in this work. The team’s focus on quality and precision helps support the FDA’s broader regulatory and public health mission.

The new task order further expands Cognizance Technologies’ ongoing support of the FDA and its Office of Computational Science. The company looks forward to continuing to contribute to the agency’s clinical and scientific priorities through dependable technical expertise and service.